Shionogi USA, Inc.
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
Shionogi USA, Inc. is a pharmaceuticals company based out of 300 Campus Dr, Florham Park, New Jersey, United States.
Strategic Acquisition Growth Shionogi USA has recently expanded its portfolio through a significant acquisition of Japan Tobacco's pharmaceutical assets, indicating a strategic focus on diversifying revenue streams and strengthening its market presence in the pharmaceutical sector. This growth trend presents opportunities to offer supporting services, technology solutions, and supply chain partnerships aligned with their expansion plans.
Government Funding & Infrastructure Development The company has secured substantial initial funding of $119 million from BARDA to establish a US-based antibiotic manufacturing facility, highlighting a focus on antimicrobial resistance and infectious disease solutions. This opens avenues for sales of manufacturing equipment, quality assurance systems, and specialized logistics services targeting pharmaceutical production.
Research & Innovation Focus Shionogi’s active participation in prominent medical conferences and recognition as a Digital Transformation Stock 2026 demonstrate its commitment to innovation and cutting-edge research, especially in neurology and digital health. Offering advanced research tools, digital health solutions, and data analytics services could align well with their ongoing investment in R&D.
Technological Advancement Utilizing diverse tech stacks such as SAS, MySQL, Medidata, and JSON shows Shionogi’s emphasis on data-driven decision-making and digital transformation. There is potential to provide data management solutions, cybersecurity, and advanced analytics platforms to support their digital initiatives and streamline research processes.
Market & Competitive Positioning With a focus on high-impact areas like neurology, infectious diseases, and antimicrobial resistance, Shionogi is targeting critical and growing segments within the pharmaceutical industry. Tailored sales strategies offering specialized APIs, clinical trial support, or therapeutic development partnerships could significantly enhance their competitive edge in the evolving healthcare landscape.
Shionogi USA, Inc. uses 8 technology products and services including SAS/GRAPH, SAS, MySQL, and more. Explore Shionogi USA, Inc.'s tech stack below.
| Shionogi USA, Inc. Email Formats | Percentage |
| First.Last@shionogi.com | 67% |
| FLast@shionogi.com | 31% |
| FirstLast@shionogi.com | 1% |
| First.Middle@shionogi.com | 1% |
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
Shionogi USA, Inc. is a pharmaceuticals company based out of 300 Campus Dr, Florham Park, New Jersey, United States.
Shionogi USA, Inc.'s revenue is estimated to be in the range of $1M$10M
Shionogi USA, Inc.'s revenue is estimated to be in the range of $1M$10M